Is There a Medical Consensus on Cannabis for Panic Disorder Treatment?

PostedMarch 3, 2026

UpdatedMarch 3, 2026

ByMy Patient Advice

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Understanding the medical consensus on cannabis for panic disorder is essential for patients and clinicians considering this therapy. Reviewing clinical guidelines, insights from expert panels, and the extent of formal treatment endorsement provides clarity on how cannabis is viewed within the medical community. Analysing the medical consensus on cannabis for panic highlights areas of agreement, caution, and ongoing debate.

Evaluating Professional Agreement

Professional evaluation is critical to interpret the medical consensus on cannabis for panic, ensuring safe and informed application in treatment planning.

Clinical Guidelines

Current clinical guidelines offer limited recommendations, often citing insufficient evidence to fully endorse cannabis as a standard treatment for panic disorder.

Expert Panels

Insights from expert panels indicate cautious optimism, recognising potential symptom relief while emphasising the need for more research.

Treatment Endorsement

Formal treatment endorsement remains rare, reflecting ongoing uncertainty and the need for robust clinical data to support widespread adoption.

In conclusion, the medical consensus on cannabis for panic is emerging but remains cautious. Reviewing clinical guidelines, expert panels, and treatment endorsement helps patients and healthcare providers make informed decisions while monitoring safety and effectiveness.

If you’re exploring cannabis treatment options for panic disorder, visit providers like LeafEase for personalised consultations and guidance tailored to your needs.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Panic Disorder.

Julia Sutton, MSc

Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Clarissa Morton, PharmD

Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy.